Skip to main content
    X

    XWELL Inc. (XWEL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $0.75
    +0.02 (+2.40%)

    Market Cap: $7.28M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    43%(10/23)
    Avg Surprise
    -163.64%
    Streak
    3 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 14
    		$-0.26N/AN/ABeat+82.0%
    Mar 26
    Reported Apr 21
    		$-1.51N/AN/ABeat-53.3%
    Sep 25
    Reported Nov 14
    		$-0.26N/AN/ABeat+45.5%
    Jun 25
    Reported Aug 14
    		$-0.56N/AN/ABeat+64.3%
    Mar 25
    Reported May 20
    		$-1.44N/AN/ABeat-87.5%
    Sep 24
    Reported Nov 14
    		$-0.99N/AN/ABeat+28.1%
    Jun 24
    Reported Aug 14
    		$-0.48N/AN/ABeat+63.3%
    Mar 24
    Reported Apr 16
    		$-1.57$0.00N/ABeat-1862.5%
    Sep 23
    Reported Nov 14
    		$-0.77$-0.80+3.75%Beat+40.8%
    Jun 23
    Reported Aug 14
    		$-1.37$-1.40+2.14%Beat+18.0%
    Mar 23
    Reported Apr 17
    		$-1.30$-2.60+50.00%Beat-62.5%
    Dec 22
    Reported Mar 21
    		$-0.08$-0.05-60.00%Miss-366.7%
    Sep 22
    Reported Nov 14
    		$-1.30$-1.40+7.14%Beat-230.0%
    Jun 22
    Reported Aug 15
    		$-1.67$-2.00+16.50%Beat-108.7%
    Mar 22
    Reported May 16
    		$-0.80$-1.20+33.33%Beat-300.0%
    Dec 21
    Reported Mar 15
    		$0.03$0.06-50.00%Miss+113.6%
    Sep 21
    Reported Nov 15
    		$1.00$-0.80+225.00%Beat+1100.0%
    Jun 21
    Reported Aug 16
    		$-0.80$-0.60-33.33%Miss+46.3%
    Mar 21
    Reported May 17
    		$-0.20N/A+80.00%Beat+96.1%
    Dec 20
    Reported Mar 31
    		$-0.22$-0.07-214.29%Miss+60.0%
    Sep 20
    Reported Nov 16
    		$-0.10N/AN/ABeat+98.0%
    Jun 20
    Reported Aug 19
    		$-1.49N/AN/ABeat+84.6%
    Mar 20
    Reported Apr 20
    		$-5.07N/AN/ABeat-5.0%
    Dec 19
    Reported Mar 31
    		$-0.55N/A+60.71%Beat+99.0%
    Sep 19
    Reported Nov 14
    		$-5.04$-1.40-260.00%Miss+95.7%
    Jun 19
    Reported Aug 14
    		$-9.66$-1.40-590.00%Miss+91.1%
    Mar 19
    Reported May 15
    		$-4.83$-2.00-141.50%Miss+97.2%
    Dec 18
    Reported Mar 28
    		$-52.77$-2.20-2298.64%Miss-109.4%
    Sep 18
    Reported Nov 14
    		$-116.16$-144.00+19.33%Beat+49.1%
    Jun 18
    Reported Aug 14
    		$-108.12$-84.00-28.71%Miss+67.8%
    Mar 18
    Reported May 15
    		$-170.04$-96.00-77.13%Miss-733.5%
    Dec 17
    Reported Mar 29
    		$-25.20$-6.00-320.00%Miss-82.6%
    Sep 17
    Reported Nov 9
    		$-228.00$-132.00-72.73%Miss-
    Jun 17
    Reported Aug 9
    		$-336.00$-156.00-115.38%Miss-
    Mar 17
    Reported May 15
    		$-20.40N/AN/ABeat-
    Dec 16
    Reported Mar 30
    		$-13.80N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.47xFCF Yield-212.41%
    Profitability
    Profit Margin-82.90%Operating Margin-26.10%
    ROE-361.40%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage54.04x
    Current Ratio2.27xQuick Ratio2.21x
    Trading Statistics
    Beta0.94Avg Volume44.48K
    52-Week High$2.2052-Week Low$0.26

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.82
    SMA 20$0.85
    SMA 50$0.92
    SMA 200$0.99
    EMA 10$0.81
    EMA 20$0.84
    EMA 50$0.91
    EMA 200$0.99

    MACD

    Line: -0.04Signal: -0.03Hist: -0.01

    ADX

    ADX: 17.7+DI: 13.4-DI: 30.3

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down100.0
    PSAR$0.94

    Bollinger Bands

    Upper Band$0.96
    Lower Band$0.74
    %B Position2589%(Upper)
    Band Width0.04

    RSI (14-Day)

    Neutral
    34.9

    Momentum Oscillators

    Stoch %K14.0
    Stoch %D13.3
    Williams %R-78.5
    ROC (10d)-9.0%
    Momentum-0.07
    CCI (20d)-197.6
    MFI (14d)19.0

    Volatility Measures

    ATR (14d)$0.06(7.9%)
    StdDev (20d)0.06
    Hist Vol71.7%(High)

    Volume Flow

    VWAP$0.73
    OBV489.7M
    AD Line-7.9M
    CMF (20d)-0.321

    Volume Metrics

    Avg Vol (20d)46.8K
    Vol Ratio1.8x(High)
    VWMA (20d)$0.83

    Pivot Points

    R3$0.85
    R2$0.82
    R1$0.78
    Pivot Point$0.75
    S1$0.70
    S2$0.67
    S3$0.62

    Advanced Oscillators

    TSI-23.58
    Ultimate Osc34.1
    KST-122.16

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$7.14M$6.64M$7.15M$7.34M$7.69M$7.02M$7.47M$8.42M$9.28M$8.73M$7.40M$7.47M
    Cost of Revenue$4.20M$4.29M$4.23M$5.85M$5.91M$5.70M$6.35M$6.37M$6.20M$6.05M$6.53M$6.38M
    Gross Profit$2.95M$2.35M$2.92M$1.49M$1.77M$1.32M$1.12M$2.05M$3.08M$2.67M$878,000$1.09M
    Operating Expenses$5.05M$7.77M$11.97M$2.26M$4.47M$4.48M$8.78M$6.82M$4.97M$5.05M$5.98M$13.18M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$4.65M$7.59M$5.86M$1.55M$4.28M$4.31M$4.77M$6.42M$4.72M$4.17M$687,000$3.00M
    Operating Income$-2,104,000$-5,414,000$-9,050,000$-770,000$-2,692,000$-3,158,000$-7,666,000$-4,769,000$-1,893,000$-2,379,000$-5,105,000$-12,089,000
    Interest Income$188,000$-22,000$-23,000$31,000$58,000$-5,000$63,000$106,000$52,000$135,000$0$0
    Interest Expense$-11,000$43,000$34,000$-490,000$-147,000$-58,000$-73,000$-100,000$-97,000$-110,000$155,000$-105,000
    Income Before Tax$-1,832,000$-11,012,000$-9,262,000$-209,000$-2,018,000$-4,588,000$-7,587,000$-4,705,000$-1,791,000$-2,358,000$-4,895,000$-11,591,000
    Income Tax Expense$51,000$0$0$2,000$34,000$0$0$0$0$0$0$0
    Net Income$-1,883,000$-11,012,000$-9,255,000$-211,000$-2,052,000$-4,588,000$-7,636,000$-4,705,000$-1,791,000$-2,358,000$-4,930,000$-11,591,000
    EBITDA$-1,795,000$-10,690,000$-8,718,000$-282,000$-1,792,000$-4,229,000$-7,083,000$-4,335,000$-1,394,000$-2,092,000$-4,841,000$-10,749,000
    EBIT$-2,031,000$-10,947,000$-9,205,000$-730,000$-2,223,000$-4,641,000$-7,723,000$-4,911,000$-1,940,000$-2,603,000$-5,454,000$-11,696,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XWEL

    Government Contracts

    Gov Obligations (TTM)
    $18.14M
    Gov Obligations / Revenue
    62.9%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    5.1 mo

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75D30126C21193Department of Health and Human ServicesCenters for Disease Control and Prevention$18.14MJul 6, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    XWELL Completes XpresTest Stock Repurchase Before Sale

    XWELL, Inc. announced the repurchase of 279.5 shares of XpresTest common stock for approximately $2.7 million at $9,634.09 per share. This transaction was completed ahead of XWELL's sale of its equity interests...

    The Globe and Mail•10/10/26•Somewhat-Bearish

    XWELL, Inc. Seeks Shareholder Approval for $13M Sale of XpresSpa and XpresTest to Express Wellness Group

    XWELL, Inc. is seeking shareholder approval for the proposed $13 million sale of its XpresSpa Holdings, LLC and XpresTest, Inc. subsidiaries to Express Wellness Group...

    Kalkine Media•10/8/26•Somewhat-Bullish

    XWELL Buys Back $2.7M XpresTest RSAs at $9,634/Share to Prepare Sale to Express Wellness

    XWELL has repurchased 279.5 restricted shares of its subsidiary XpresTest for approximately $2.7 million at $9,634.09 per share. This transaction, involving directors and executives...

    TradingView•10/8/26•Somewhat-Bullish

    American Ventures LLC Secures 9.975% Activist Stake in XWELL, Inc. (NASDAQ: XWEL) Following Preferred Stock Conversion

    American Ventures LLC, Series XXIV, has acquired a 9.975% activist stake in XWELL, Inc. (NASDAQ: XWEL) after converting 467 Series H Convertible Preferred Stock shares into 993,617 common shares. The activist investor...

    Kalkine Media•9/9/26•Somewhat-Bullish

    XWELL Director Reid Gerard Granted 150,000 Shares, Establishing New Insider Stake

    XWELL, Inc. director Reid Gerard was awarded 150,000 shares on August 25, 2026, marking a new insider position for him. This transaction brings his total reported ownership to 150,000 XWELL shares...

    Kalkine Media•9/9/26•Somewhat-Bullish

    XWEL Valuation and Fair Value

    Forward P/E
    10.8x
    P/FCF
    -0.5x
    P/B
    -3.4x
    See GNG's fair value

    XWEL Profitability: Margins, ROIC and FCF

    Gross margin
    34.3%
    Operating margin
    -26.1%
    Net margin
    -82.9%
    ROE
    -361.4%
    FCF margin
    -47.7%
    FCF yield
    -212.4%

    XWEL Competitors

    CompanyTicker
    Soligenix Inc.SNGX
    InMed Pharmaceuticals IncINM
    Aprea Therapeutics IncAPRE
    Predictive Oncology IncPOAI
    Senti Biosciences IncSNTI
    Skye Bioscience, Inc. Common StockSKYE
    Tenon Medical IncTNON
    FibroBiologics, Inc. Common StockFBLG

    Sector: Healthcare

    XWEL Bull Case vs Bear Case

    Bull case

    • XWEL beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • XWEL has a -82.9% net profit margin.
    • XWEL's quarterly revenue changed -7.1% year over year.

    XWEL Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    7.6%

    Frequently Asked Questions About XWEL

    Does XWEL pay dividends?

    XWELL Inc. (XWEL) does not currently pay a regular dividend.

    What is XWEL's market cap?

    XWELL Inc. (XWEL) has a market capitalization of $7.28M with a current stock price of $0.75.

    Related stocks

    Sector: Healthcare

    All stocks starting with X

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In